The drug repurposing service providers market is estimated to be worth USD 1.2 billion in 2030
Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs
Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Market, 2020-2030.”
To...
0 Comments
0 Shares